Integrated Advisors Network LLC Makes New Investment in HealthEquity, Inc. (NASDAQ:HQY)

Integrated Advisors Network LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 2,936 shares of the company's stock, valued at approximately $259,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HQY. Arcadia Investment Management Corp MI bought a new position in HealthEquity in the fourth quarter valued at about $26,000. Versant Capital Management Inc bought a new position in shares of HealthEquity in the first quarter worth about $28,000. Transce3nd LLC purchased a new stake in HealthEquity during the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC increased its holdings in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares during the last quarter. Finally, Proficio Capital Partners LLC bought a new position in HealthEquity during the fourth quarter valued at approximately $39,000. Institutional investors own 99.55% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on HQY shares. Bank of America lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. JMP Securities upped their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft lifted their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada increased their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Finally, KeyCorp cut their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $118.09.

Insider Buying and Selling

In related news, Director Jon Kessler sold 134,183 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director now owns 253,510 shares in the company, valued at $28,413,400.80. This represents a 34.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president now owns 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 304,581 shares of company stock valued at $33,664,018. Corporate insiders own 1.50% of the company's stock.

HealthEquity Stock Performance

NASDAQ:HQY traded up $1.80 during midday trading on Wednesday, hitting $101.81. The company's stock had a trading volume of 366,195 shares, compared to its average volume of 1,041,310. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $116.65. The firm's 50 day moving average is $94.79 and its 200-day moving average is $97.84. The firm has a market cap of $8.80 billion, a P/E ratio of 74.31, a P/E/G ratio of 1.54 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same period last year, the firm earned $0.80 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.